Delivery Order SPE2DB24D1034-SPE2DB25FWFW2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $37,492.95 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 88 micrograms, a thyroid hormone replacement medication. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,630.09 to AmerisourceBergen Drug Corp for the supply of Synthroid 50 MCG tablets (1,000 units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order under the competitive procurement process. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Synthroid 25 microgram tablets (1,000 count) under a firm fixed-price contract valued at $1,430.00. The award, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a competitively awarded, non-set-aside transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in the same city. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,931.37 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 50 micrograms. The contract, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.98 to AmerisourceBergen Drug Corp for the supply of Synthroid 25 microgram tablets (90-count units) on August 26, 2025, with completion expected by August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Synthroid 100 micrograms tablets in quantities of 1,000 units, with a ceiling value of $1,061.94. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is due for completion by September 16, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of 1,000 tablets of Synthroid 25 micrograms, with a ceiling value of $1,539.70. This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and is scheduled for completion by August 6, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,213.91 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 175 mcg on September 10, 2025, with completion expected by September 11, 2025. This delivery order was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Synthroid is a synthetic thyroid hormone medication commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Synthroid 100 microgram tablets in quantities of 1,000 units, with a ceiling value of $1,678.76. This non-competitive, firm fixed price delivery order is set to be completed by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,537.98 delivery order to AmerisourceBergen Drug Corp for 1,000 units of Synthroid 25 micrograms on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement under delivery order contract type. The award was placed to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the vendor is headquartered...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB25FWFW2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,231.14 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 50 mcg. This firm fixed-price delivery order, issued on September 17, 2025, with completion targeted for September 18, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems. The contract carries no set-aside designation, indicating it was competitively awarded through open competition. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements across multiple therapeutic domains, combined with its role as a pharmaceutical prime vendor, positions it to serve the DLA's substantial medication supply needs across the global defense healthcare enterprise.